SCD and breast cancer: The cannabinoid receptor 1 inhibitor LIMONENE can activate the PI3K and MAPK signaling pathways, reduce MUFA generation mediated by SCD1 and fatty acid desaturase 2, promote ferroptosis in TNBC cells, increase sensitivity of cancer tissue to erastin and RSL3, and limit the growth of breast cancer tissue in vivo (121).